Crystal system: triclinic
a: | 11.3032 (±0.0013) Å |
b: | 11.6338 (±0.0013) Å |
c: | 21.602 (±0.002) Å |
α: | 82.26 (±0.004)° |
β: | 86.069 (±0.005)° |
γ: | 89.888 (±0.005)° |
Starting materials: 2T•HBr (2T: bithiophenylethylammonium), lead bromide (PbBr2), dimethylformide (DMF), anhydrous chlorobenzene (CB)
Product: sheet-like crystals
Description: 10 μmol of PbBr2 and 20 μmol of 2T•HBr were dissolved in 2 mL of DMF/CB co-solvent (1:1 ratio). This resulted in 5 mM of stock solution. This solution was diluted 120 times by CB/An/DCB cosolvent (2.5:1:0.01 volume ratio). Only 5-10 μmol was placed on a growth substrate SiO2, at the bottom of a glass vial and was later transferred to another vial with 3 mL of CB. This was placed on a 70º hot plate. Growth took 10-30 minutes.
Method: Single Crystal X-Ray Diffraction
Description: Bruker AXS D8 Quest CMOS diffractometer with kappa geometry, an I-μ-S microsource X-ray tube, multilayer Göbel mirror, and Photon2 CMOS was used. Data was collected with Cu Kα radiation (λ = 1.54178 Å).